Glastonbury, CT, United States of America

Li-Quang Sun

This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2003-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Li-Quang Sun. Retrieved from https://idiyas.com/inventor/li-quang-sun

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 33.3


Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2003-2004

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Li-Quang Sun

Introduction

Li-Quang Sun is a notable inventor based in Glastonbury, CT (US). He has made significant contributions to the field of pharmacology, particularly in the development of novel compounds. With a total of 3 patents to his name, his work has the potential to impact various therapeutic areas.

Latest Patents

Li-Quang Sun's latest patents include innovative compounds such as Cinnamide derivatives as KCNQ potassium channel modulators and Thiophenyl triazol-3-one derivatives as smooth muscle relaxants. These inventions showcase his expertise in creating effective pharmaceutical agents.

Career Highlights

Li-Quang Sun is currently employed at Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His role involves research and development, where he applies his knowledge to advance medical science and improve patient outcomes.

Collaborations

Throughout his career, Li-Quang Sun has collaborated with esteemed colleagues, including Piyasena Hewawasam and Katherine S. Takaki. These partnerships have fostered a collaborative environment that enhances innovation and research productivity.

Conclusion

Li-Quang Sun's contributions to the field of pharmacology through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments and therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…